Trial Profile
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2015
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary) ; Peginesatide
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Amgen
- 30 Apr 2015 New trial record